# OR2T33

## Overview
OR2T33 is a gene that encodes the protein olfactory receptor family 2 subfamily T member 33, which is part of the G-protein-coupled receptor (GPCR) family. These receptors are integral membrane proteins involved in the detection of odor molecules, playing a crucial role in the olfactory system by initiating signal transduction pathways that lead to the perception of smell (Raka2021Human). Beyond its primary function in olfaction, OR2T33 is expressed in various brain regions, including the frontal cortex and cerebellum, suggesting potential roles in neurological processes (Ansoleaga2013Dysregulation). While its specific functions in the brain are not fully understood, alterations in OR2T33 expression have been observed in certain psychiatric conditions, such as schizophrenia, indicating a possible involvement in the molecular pathology of these disorders (Ansoleaga2015Decrease). However, its expression remains largely unchanged in neurodegenerative diseases like Alzheimer's and Parkinson's, suggesting a more specific role in psychiatric rather than neurodegenerative conditions (GarciaEsparcia2013Functional).

## Function
OR2T33 is an olfactory receptor gene that encodes a protein belonging to the G-protein-coupled receptor (GPCR) family. These receptors are primarily involved in detecting odor molecules and initiating signal transduction pathways that result in the perception of smell. OR2T33 is expressed in the olfactory epithelium, where it binds specific odorants, contributing to the sense of smell (Raka2021Human).

In addition to its role in olfaction, OR2T33 is expressed in various brain regions, including the frontal cortex, entorhinal cortex, and cerebellum, suggesting potential roles beyond olfaction (Ansoleaga2013Dysregulation). The expression of OR2T33 in the brain indicates that it may be involved in broader neurological functions, although its specific roles in healthy human cells remain to be fully elucidated (Santos2019The).

Research has shown that OR2T33 expression is down-regulated in the dorsolateral prefrontal cortex of individuals with chronic schizophrenia, suggesting a potential involvement in the molecular pathology of the disorder (Ansoleaga2015Decrease). This down-regulation is associated with antipsychotic treatment, indicating that OR2T33 may be influenced by medication (Ansoleaga2015Decrease).

## Clinical Significance
The gene OR2T33 has been studied in the context of several neurological and psychiatric conditions, although specific mutations in OR2T33 have not been directly linked to any particular disease. In chronic schizophrenia, OR2T33 expression is significantly down-regulated in the dorsolateral prefrontal cortex. This down-regulation is associated with the daily dose of antipsychotic medication, suggesting a potential link between OR2T33 expression and the pharmacological treatment of schizophrenia (Ansoleaga2015Decrease). The study indicates that the decrease in OR2T33 expression may contribute to the cognitive alterations observed in schizophrenia, although the exact mechanisms remain unclear (Ansoleaga2015Decrease).

In neurodegenerative diseases such as Alzheimer's disease, progressive supranuclear palsy, and Creutzfeldt-Jakob disease, OR2T33 expression does not show significant changes in the frontal cortex or other brain regions, indicating that its expression is not notably affected in these conditions (Ansoleaga2013Dysregulation). Similarly, in Parkinson's disease, OR2T33 expression levels remain unchanged compared to controls, suggesting that it is not significantly dysregulated in this context (GarciaEsparcia2013Functional). Overall, while OR2T33 expression is altered in schizophrenia, its role in other diseases is less clear, and no specific mutations have been linked to clinical conditions.


## References


[1. (Ansoleaga2015Decrease) Belén Ansoleaga, Paula Garcia-Esparcia, Raquel Pinacho, Josep Maria Haro, Belén Ramos, and Isidre Ferrer. Decrease in olfactory and taste receptor expression in the dorsolateral prefrontal cortex in chronic schizophrenia. Journal of Psychiatric Research, 60:109–116, January 2015. URL: http://dx.doi.org/10.1016/j.jpsychires.2014.09.012, doi:10.1016/j.jpsychires.2014.09.012. This article has 54 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jpsychires.2014.09.012)

[2. (Ansoleaga2013Dysregulation) B. Ansoleaga, P. Garcia-Esparcia, F. Llorens, J. Moreno, E. Aso, and I. Ferrer. Dysregulation of brain olfactory and taste receptors in ad, psp and cjd, and ad-related model. Neuroscience, 248:369–382, September 2013. URL: http://dx.doi.org/10.1016/j.neuroscience.2013.06.034, doi:10.1016/j.neuroscience.2013.06.034. This article has 63 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.neuroscience.2013.06.034)

[3. (Santos2019The) C.R.A. Santos, A.C. Duarte, A.R. Costa, J. Tomás, T. Quintela, and I. Gonçalves. The senses of the choroid plexus. Progress in Neurobiology, 182:101680, November 2019. URL: http://dx.doi.org/10.1016/j.pneurobio.2019.101680, doi:10.1016/j.pneurobio.2019.101680. This article has 20 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.pneurobio.2019.101680)

[4. (Raka2021Human) Rifat Nowshin Raka, Hua Wu, Junsong Xiao, Imam Hossen, Yanping Cao, Mingquan Huang, and Jianming Jin. Human ectopic olfactory receptors and their food originated ligands: a review. Critical Reviews in Food Science and Nutrition, 62(20):5424–5443, February 2021. URL: http://dx.doi.org/10.1080/10408398.2021.1885007, doi:10.1080/10408398.2021.1885007. This article has 10 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1080/10408398.2021.1885007)

[5. (GarciaEsparcia2013Functional) Paula Garcia-Esparcia, Agatha Schlüter, Margarita Carmona, Jesús Moreno, Belen Ansoleaga, Benjamín Torrejón-Escribano, Stefano Gustincich, Aurora Pujol, and Isidre Ferrer. Functional genomics reveals dysregulation of cortical olfactory receptors in parkinson disease: novel putative chemoreceptors in the human brain. Journal of Neuropathology &amp; Experimental Neurology, 72(6):524–539, June 2013. URL: http://dx.doi.org/10.1097/NEN.0b013e318294fd76, doi:10.1097/nen.0b013e318294fd76. This article has 135 citations.](https://doi.org/10.1097/NEN.0b013e318294fd76)